Thomas Klag1, Eduard F Stange2, Jan Wehkamp3. 1. Department of Internal Medicine I, Robert-Bosch-Hospital, Stuttgart, Germany ; Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany. 2. Department of Internal Medicine I, Robert-Bosch-Hospital, Stuttgart, Germany. 3. Department of Internal Medicine I, University of Tübingen, Tübingen, Germany.
Abstract
BACKGROUND: Management of Crohn's disease (CD) is a clinical challenge. In terms of an evidence-based approach, clinical guidelines help to deal with this challenge. However, little is known about guideline adherence concerning the management of CD in Germany. OBJECTIVE: To survey German gastroenterologists with regards to their guideline adherence in daily clinical care. METHOD: A web-based national survey was conducted among German gastroenterologists. RESULTS: A total of 175 inflammatory bowel disease (IBD) practitioners responded to the survey. Overall, in the different clinical situations covered in the questionnaire guideline adherence is good. However, the 5-aminosalicylic acid (5-ASA) prescribing habits represent a striking exception. About 10-36% use 5-ASA as mono-therapy in CD, depending on the clinical scenario. Predominantly it is used in mild CD and in colonic involvement. To maintain a surgically achieved remission, therapeutic decisions broadly rely on individual approaches with azathioprine and 5-ASA being used by about 30% of the respondents. Cessation of smoking as a "therapeutic" strategy of maintenance therapy is used by only half of the surveyed physicians. CONCLUSION: Amongst German IBD practitioners, the guideline adherence is good overall. Reflecting ongoing uncertainty about the efficacy of mesalazine, its use in Crohn's disease is still heterogeneous.
BACKGROUND: Management of Crohn's disease (CD) is a clinical challenge. In terms of an evidence-based approach, clinical guidelines help to deal with this challenge. However, little is known about guideline adherence concerning the management of CD in Germany. OBJECTIVE: To survey German gastroenterologists with regards to their guideline adherence in daily clinical care. METHOD: A web-based national survey was conducted among German gastroenterologists. RESULTS: A total of 175 inflammatory bowel disease (IBD) practitioners responded to the survey. Overall, in the different clinical situations covered in the questionnaire guideline adherence is good. However, the 5-aminosalicylic acid (5-ASA) prescribing habits represent a striking exception. About 10-36% use 5-ASA as mono-therapy in CD, depending on the clinical scenario. Predominantly it is used in mild CD and in colonic involvement. To maintain a surgically achieved remission, therapeutic decisions broadly rely on individual approaches with azathioprine and 5-ASA being used by about 30% of the respondents. Cessation of smoking as a "therapeutic" strategy of maintenance therapy is used by only half of the surveyed physicians. CONCLUSION: Amongst German IBD practitioners, the guideline adherence is good overall. Reflecting ongoing uncertainty about the efficacy of mesalazine, its use in Crohn's disease is still heterogeneous.
Authors: A Dignass; G Van Assche; J O Lindsay; M Lémann; J Söderholm; J F Colombel; S Danese; A D'Hoore; M Gassull; F Gomollón; D W Hommes; P Michetti; C O'Morain; T Oresland; A Windsor; E F Stange; S P L Travis Journal: J Crohns Colitis Date: 2010-01-15 Impact factor: 9.071
Authors: J C Hoffmann; J C Preiss; F Autschbach; H J Buhr; W Häuser; K Herrlinger; W Höhne; S Koletzko; C F Krieglstein; W Kruis; H Matthes; G Moser; M Reinshagen; G Rogler; S Schreiber; A G Schreyer; B Sido; B Siegmund; A Stallmach; B Bokemeyer; E F Stange; M Zeitz Journal: Z Gastroenterol Date: 2008-09-22 Impact factor: 2.000
Authors: Paul Rutgeerts; Gert Van Assche; Séverine Vermeire; Geert D'Haens; Filip Baert; Maja Noman; Isolde Aerden; Gert De Hertogh; Karel Geboes; Martin Hiele; Andre D'Hoore; Freddy Penninckx Journal: Gastroenterology Date: 2005-04 Impact factor: 22.682
Authors: Alexander C Ford; Sunanda V Kane; Khurram J Khan; Jean-Paul Achkar; Nicholas J Talley; John K Marshall; Paul Moayyedi Journal: Am J Gastroenterol Date: 2011-03-15 Impact factor: 10.864
Authors: I Blumenstein; W Tacke; N Filmann; C Zosel; H Bock; V Heuzeroth; S Zeuzem; O Schröder Journal: Z Gastroenterol Date: 2013-05-21 Impact factor: 2.000
Authors: Johan Burisch; Daniel Bergemalm; Jonas Halfvarson; Viktor Domislovic; Zeljko Krznaric; Adrian Goldis; Jens F Dahlerup; Pia Oksanen; Pekka Collin; Luisa de Castro; Vicent Hernandez; Svetlana Turcan; Elena Belousova; Renata D'Incà; Alessandro Sartini; Daniela Valpiani; Martina Giannotta; Ravi Misra; Naila Arebi; Dana Duricova; Martin Bortlik; Kelly Gatt; Pierre Ellul; Natalia Pedersen; Jens Kjeldsen; Karina W Andersen; Vibeke Andersen; Konstantinos H Katsanos; Dimitrios K Christodoulou; Shaji Sebastian; Luisa Barros; Fernando Magro; Jóngerð Mm Midjord; Kári R Nielsen; Riina Salupere; Hendrika Al Kievit; Gediminas Kiudelis; Juozas Kupčinskas; Mathurin Fumery; Corinne Gower-Rousseau; Ioannis P Kaimakliotis; Doron Schwartz; Selwyn Odes; Laszlo Lakatos; Peter L Lakatos; Ebbe Langholz; Pia Munkholm Journal: United European Gastroenterol J Date: 2020-07-26 Impact factor: 4.623
Authors: Jan Wehkamp; Martin Götz; Klaus Herrlinger; Wolfgang Steurer; Eduard F Stange Journal: Dtsch Arztebl Int Date: 2016-02-05 Impact factor: 5.594
Authors: Ryan C Ungaro; Berkeley N Limketkai; Camilla Bjørn Jensen; Clara Yzet; Kristine H Allin; Manasi Agrawal; Thomas Ullman; Johan Burisch; Tine Jess; Jean-Frederic Colombel Journal: Clin Gastroenterol Hepatol Date: 2019-08-13 Impact factor: 11.382
Authors: Shomron Ben-Horin; Jane M Andrews; Konstantinos H Katsanos; Florian Rieder; Flavio Steinwurz; Konstantinos Karmiris; Jae Hee Cheon; Gordon William Moran; Monica Cesarini; Christian D Stone; Doron Schwartz; Marijana Protic; Xavier Roblin; Giulia Roda; Min-Hu Chen; Ofir Har-Noy; Charles N Bernstein Journal: World J Gastroenterol Date: 2017-04-28 Impact factor: 5.742
Authors: Mohamed Noureldin; Shirley Cohen-Mekelburg; Asadullah Mahmood; Ryan Stidham; Peter D R Higgins; Shail Govani; Amar R Deshpande; Akbar K Waljee Journal: Inflamm Bowel Dis Date: 2021-03-15 Impact factor: 5.325
Authors: Zsuzsanna Kurti; Akos Ilias; Lorant Gonczi; Zsuzsanna Vegh; Petra Fadgyas-Freyler; Gyula Korponay; Petra A Golovics; Barbara D Lovasz; Peter L Lakatos Journal: BMC Gastroenterol Date: 2018-01-30 Impact factor: 3.067